While increased tissue ACE2 levels likely facilitates infection of cells with SARS-CoV-2, the effect of elevated circulating levels of ACE2 per se on the pathogenesis of COVID-19 is less understood [51]. This evidence concerns the gene ACE2 and COVID-19.